RNA

Business Adam Feuerstein

Stakes are high as Alnylam awaits results from novel rare disease therapy

Biotech Meghana Keshavan

When a Nobel Prize brings a shower of hype: the roller coaster ride of RNAi

Business Damian Garde

No stranger to gambling, this biotech CEO is going all-in on a first drug approval

Business Andrew Joseph

Breast cancer patients encouraged to share genetic data